Evidence
is emerging that dietary isoflavones play a beneficial
role in the management of diabetes. Adding soy to the
diet provides a wide range of health benefits, many of
which are applicable to a person with diabetes. Benefits
include favorably altering insulin resistance, glycemic
control, and serum lipid control, which can improve the
cardiovascular risk profile.
In
a randomized, double blind, cross-over trial of dietary
soy supplementation (Jayagopal et al., 2002) 32 women
with diet controlled type 2 diabetes received 30 grams
of soy protein per day (containing 132 mg isoflavones)
or placebo for 12 weeks. When compared with the mean percentage
change from baseline seen after 12 weeks of placebo, isoflavone
supplementation resulted in significantly lower mean values
for fasting insulin (P = 0.006), insulin resistance (P
= 0.003), HbA1C (P = 0.048), total cholesterol (P = 0.004),
LDL cholesterol (P = 0.001), HDL/LDL ratio (P = 0.015)
and free thyroxine (P = 0.004).
In
a recent cross-sectional study of Chinese women in Shanghai,
the relationship between dietary soy intake and the risk
of developing glycosuria, a risk factor for diabetes,
was examined. In this study, it was reported that higher
levels of soy intake were associated (P for trend = 0.05)
with a decreased risk of glycosuria in postmenopausal
women with a low BMI (Yang et al., 2004).
One
potential reason for soy’s apparent beneficial effects
on diabetes risk is that soy is a low glycemic food. Soy’s
low glycemic index helps to keep blood glucose levels
under control. This is especially important for people
with diabetes. Many experts believe that a high carbohydrate
diet is best for people with diabetes. However, carbohydrates
can raise blood glucose to dangerous levels, which lead
many medical professionals to recommend a low carbohydrate
diet. However, not all carbohydrates act the same. Some
are quickly broken down in the intestine causing the blood
glucose levels to rise rapidly. These types of carbohydrates
are said to have a high glycemic index. Others, like soy,
are broken down more slowly and have a low glycemic index.
By consuming soy foods, a patient can get the value of
carbohydrates and keep blood glucose under control. Table
1 shows the glycemic index of a variety of soy food products
from Revival Soy.
Another
advantage of low glycemic foods is that they prevent the
spikes in blood sugar often observed with high glycemic
foods. These blood sugar spikes cause food cravings and
often result in binge eating that destroys so many diets.
The consumption of low glycemic foods is becoming recognized
as a smart way to eat since it helps with weight loss
and is particularly helpful to diabetics for controlling
blood sugar levels.
In
addition to potential direct beneficial effects of soy
on diabetes, adding soy to the diet may also provide health
benefits for conditions associated with diabetes, including
nephropathy, CHD, and weight loss. Soy can help improve
kidney function in diabetes patients with nephropathy.
Azadkbakht et al. (2003) conducted a study among 14 women
and men and concluded that soy can modify the risk factors
of heart disease and improve kidney function in patients
with type II diabetes. A study conducted by Teixeira et
al. (2004) found that isolated soy protein consumption
improves several markers that may be beneficial for type
2 diabetic men with nephropathy.
Table
1. The Glycemic Index of Revival Soy products
Glycemic Index
Product, Carbohydrates (grams), Value, Category*
Chocolate Splenda Shake 34 25 Low
Choclolate Fructose Shake 36 33 Low
Chocolate Raspberry Bar 33 (6 net) 47 Low
Peanut Chocolate Pal Bar 31 52 Low
Soy Spaghetti (boiled) 34 47 Low
*Glycemic Index Categories: <55 = Low Glycemic Food;
56-69 = Medium GI Food; >70 = High Glycemic Goods
Soy
works to improve serum lipids and has other cardiovascular
benefits. Studies have demonstrated that adding soy to
the diet can lower total cholesterol and lower LDL cholesterol
(Anderson et al., 1995). In addition soy has been shown
to improve arterial compliance (Nestel et al., 1997) and
modify LDL oxidation (Wiseman et al., 2000)
Recent
clinical trials have begun to describe the weight loss
benefits of soy protein (Allison et al., 2003; Fontaine
et al., 2003; Goodman-Gruen and Kritz-Silverstein, 2003;
Deibert et al., 2004). While the exact mechanism of action
is not clear there is preliminary work that suggests that
genistein reduces adipose deposition in mice (Naaz et
al., 2003). It has also been reported that genistein effects
lipid metabolism and adipocyte proliferation (Nogowski
et al., 1998; Harmon and Harp, 2001). Finally, soy protein
may work to suppress food intake and gastric emptying
through the ?-conglycinin peptone (Nishi et al., 2003).
REFERENCES
1. Jayagopal, V, Albertazzi P, Kilpatrick
ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial
effects of soy phytoestrogen intake in postmenopausal
women with Type 2 diabetes. Diabetes Care 2002; 25:1709-1714
2. Yang G, Shu XO, Jin F, Elasy T, Li HL, Li Q, Huang
F, Zhang XL, Gao YT, Zheng W. Soyfood consumption and
risk of glycosuria: a cross-sectional study within the
Shanghai Women’s Health Study. Europ J Clin Nutr
2004; 58:615-620
3. Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian
M, Mehrabi Y, Esmaill-Zadeh A, Beneficiary effect of dietary
soy protein on lowering plasma level lipids and improving
kidney function in type II diabetes with nephropathy,
Eur J Clin Nutr. 2003 Oct; 57(10): 1292-4
4. Teixeira SR, Tappenden KA, Carson L, Jones R. Parabhudesai
M, Marsl WP, Erdman JW Jr, Isolated soy protein consumption
reduces urinary albumin excretion and improves the serum
lipid profile in men with type 2 diabetes mellitus and
nephropathy, J Nutr, 2004 Aug 13; 134(8): 1874-80
5. Anderson, J, Johnstone, B, Cook-Newell, M, Meta-Analysis
of the effects of soy protein intake on serum lipids,
The New England Journal of Medicine, Aug 1995, 276-282
6. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones
improve systemic arterial compliance but not plasma lipids
in menopausal and perimenopausal women. Arterioscler Throm
Vasc Biol. 1997; 17: 3392-3398
7. Wiseman, H, O’Reilly, J D, Aldercreutz, A, et
al. Isoflavone phytoestrogens consumed in soy decrease
F2-isoprostane concentrations and increase resistance
of low-density lipoprotein to oxidation in humans, Am
J Clin Nutr 2000; 72:395-400.
8. Allison DB, Gadbury G, Schwartz LG, Murugesan R, Kraker
JL, Heshka S, Fontaine KR, Heymsfield SB. A novel soy-based
meal replacement formula for weight loss among obese individuals:
a randomized controlled clinical trial. European Journal
of Clinical Nutrition 2003; 57:514-522
9. Fontaine KR, Yang D, Gadbury GL, Heshka S, Schwartz
LG, Murugesan R, Kraker JL, Heo M, Heymsfield SB, Allison
DB. Results of a soy-based meal replacement formula on
weight, anthropometry, serum lipids & blood pressure
during a 40-week clinical weight loss trial. BMC Nutrition
Journal 2003; 2:14-20.
10. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary
isoflavone intake and body composition in postmenopausal
women. Menopause 2003; 10:427-432.
11. Deibert P, Konig D, Schmidt-Trucksaess A, Zaenker
KS, Frey I, Landmann U, Berg A. Weight loss without losing
muscle mass in pre-obese and obese subjects induced by
a high-soy-protein diet. International Journal of Obesity
2004; 28:1349-1352 (doi: 10.1038/sj.ijo.0802765 Published
online 10 August 2004)
12. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge
DR, Lubahn DB, Helferich WG, Cooke PS. The soy isoflavone
genistein decreases adipose deposition in mice. Endocrinology
2003; 144:3315-3320
13. Nogowski L, Mackowiak P, Kandulska K, Szkudelski T,
Nowak KW. Genistein-induced changes in lipid metabolism
of ovariectomized rats. Ann Nutr Metab 1998; 42:360-366
14. Harmon AW, Harp JB. Differential effects of flavonoids
on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell
Physiol 2001; 280:C807-C813
15. Nishi T, Hara H, Tomita F. Soybean b-conglycinin peptone
suppresses food intake and gastric emptying by increasing
plasma cholecystokinin levels in rats. Journal of Nutrition
2003; 133:352-357
Please
visit www.revivalsoy.com
for further information